Teo Hansen Selnø, Anette, Schlichtner, Stephanie, Yasinska, Inna M., Sakhnevych, Svetlana S., Fiedler, Walter, Wellbrock, Jasmin, Berger, Steffen M., Klenova, Elena, Gibbs, Bernhard F, Fasler-Kan, Elizaveta, and others. (2021) High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells. Frontiers in Immunology, 12 . Article Number 675731. E-ISSN 1664-3224. (doi:10.3389/fimmu.2021.675731) (KAR id:90457)
PDF
Publisher pdf
Language: English
This work is licensed under a Creative Commons Attribution 4.0 International License.
|
|
Download this file (PDF/2MB) |
![]() |
Request a format suitable for use with assistive technology e.g. a screenreader | |
Official URL: https://doi.org/10.3389/fimmu.2021.675731 |
Abstract
High mobility group box 1 (HMGB1) is a non-histone protein which is predominantly localised in the cell nucleus. However, stressed, dying, injured or dead cells can release this protein into the extracellular matrix passively. In addition, HMGB1 release was observed in cancer and immune cells where this process can be triggered by various endogenous as well as exogenous stimuli. Importantly, released HMGB1 acts as a so-called “danger signal” and could impact on the ability of cancer cells to escape host immune surveillance. However, the molecular mechanisms underlying the functional role of HMGB1 in determining the capability of human cancer cells to evade immune attack remain unclear. Here we report that the involvement of HMGB1 in anti-cancer immune evasion is determined by Toll-like receptor (TLR) 4, which recognises HMGB1 as a ligand. We found that HGMB1 induces TLR4-mediated production of transforming growth factor beta type 1 (TGF-β), displaying autocrine/paracrine activities. TGF-β induces production of the immunosuppressive protein galectin-9 in cancer cells. In TLR4-positive cancer cells, HMGB1 triggers the formation of an autocrine loop which induces galectin-9 expression. In malignant cells lacking TLR4, the same effect could be triggered by HMGB1 indirectly through TLR4-expressing myeloid cells present in the tumour microenvironment (e. g. tumour-associated macrophages).
Item Type: | Article |
---|---|
DOI/Identification number: | 10.3389/fimmu.2021.675731 |
Uncontrolled keywords: | galectin-9, TGF-beta 1, HMGB1 (high mobility group box 1), immune surveillance, Toll-like receptors |
Subjects: | R Medicine > RS Pharmacy and materia medica |
Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
Depositing User: | Vadim Sumbayev |
Date Deposited: | 29 Sep 2021 13:41 UTC |
Last Modified: | 10 Dec 2022 06:05 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/90457 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):